-
Published21/11/2018
-
Deadline31/12/2020
-
Opening of tenders31/12/2020
-
Today08/11/2025
Utilities
- indicates text translated automatically in your browsing language
Germany-Hamburg: Pharmaceutical products
The health insurance funds involved pursue the objective of concluding discount agreements with all appropriate pharmaceutical companies pursuant to Paragraphs 130a(8) and 130c(1) of the SGB V for the active ingredient tofacitinib.
The contract is concluded as part of the health insurance funds’ open-house procedure:
Individual negotiations on the content of the contract are not conducted and uniform conditions apply. The health insurance funds do not grant exclusivity to individual contracting parties. The maximum duration of the contract is 24 months starting from 101.2019. The contract will end no later than 31.12.2020, irrespective of the date of conclusion of the contract. Accession to this open-house procedure is possible at any time during the duration of the contract. All further information can be found in the participation and contract documents. If the patent expires before 31.12.2020, the contract ends automatically at the end of the month in which the patent expires.
Text automatically translated in your browsing language
Automatically translated
Official name: Techniker Krankenkasse
Postal address: Bramfelder Str. 140
Town: Hamburg
NUTS code: DE6
Postal code: 22305
Country: DEU
Main address: www.tk.de/vergabe
VIACTIV Krankenkasse
pronova BKK
Novitas BKK
HEK – Hanseatische Krankenkasse
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.